Patents by Inventor Matthias Oberli

Matthias Oberli has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240003890
    Abstract: Particle-based detection of analytes including, for example, systems, kits, and methods for growth, isolation, and/or monitoring of analytes are generally disclosed. In some embodiments, the systems and methods described herein are generally directed to the capture and/or concentrating of a target species (e.g., analyte) to be detected and/or monitored. In some embodiments, the materials, systems, and methods described herein may be used to create luminescent signals in response to the presence of selected analytes such as bacteria, viruses, and parasites. In some cases, the target analyte is a pathogenic bacteria, a pathogenic virus, a pathogenic parasite, or toxin.
    Type: Application
    Filed: November 17, 2021
    Publication date: January 4, 2024
    Applicant: Xibus Systems, Inc.
    Inventors: Timothy Manning Swager, Kent Harvey, Matthias Oberli
  • Publication number: 20230258618
    Abstract: Rapid detection of analytes including, for example, systems, kits, and methods for growth, isolation, and/or monitoring of analytes are generally disclosed. In some embodiments, the systems and methods described herein are generally directed to the capture and/or concentrating of a target species (e.g., analyte) to be detected and/or monitored. In some embodiments, the materials, systems, and methods described herein may be used to create luminescent signals in response to the presence of selected analytes such as bacteria, viruses, and parasites. In some cases, the target analyte is a pathogenic bacteria, a pathogenic virus, a pathogenic parasite, or toxin.
    Type: Application
    Filed: January 26, 2023
    Publication date: August 17, 2023
    Applicant: Xibus Systems, Inc.
    Inventors: Timothy Manning Swager, Peter L. Antionette, Matthias Oberli, Brandon Selover, Kent Harvey
  • Publication number: 20130344104
    Abstract: The present invention provides an oligosaccharide-protein conjugate comprising an oligosaccharide, in particular synthetic oligosaccharide, derived from the repeating unit of the Clostridium difficile glycopolymer PS-II and a protein carrier. More specifically, the oligosaccharide is the hexasaccharide having the following formula (I) wherein R is a linker or spacer group. In a specific embodiment of the invention, R is (CH2)nNH2, with n being an integer from 2 to 50. The present invention also provides the use of said oligosaccharide and said oligosaccharide-protein conjugate for the treatment or prevention of a disease caused by the pathogen Clostridium difficile. In still further aspects, the present invention also provides a favourable method for preparing said oligosaccharide and said oligosaccharide-protein conjugate.
    Type: Application
    Filed: March 7, 2012
    Publication date: December 26, 2013
    Inventors: Peter H. Seeberger, Matthias Oberli, Marie-Lyn Hecht